Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants
January 31 2019 - 4:21PM
Milestone Scientific Inc. (MLSS), a leading developer of
computerized drug delivery instruments that provide painless and
precise injections, announced today that it intends to offer for
sale a combination of shares of its common stock and warrants to
purchase shares of its common stock in an underwritten public
offering. The company intends to use the net proceeds from this
offering for general corporate purposes, including working capital.
The offering is subject to market conditions, and there can be no
assurance as to whether or when the offering may be completed, or
as to the actual size or terms of the offering.
Maxim Group LLC is acting as sole book-running
manager for the offering.
The securities described above are being offered
by Milestone Scientific pursuant to a registration statement (File
No. 333-209466) previously filed and declared effective by the
Securities and Exchange Commission (SEC). The securities are being
offered by means of a prospectus supplement and accompanying
prospectus, forming part of the registration statement. A
preliminary prospectus supplement and accompanying prospectus
relating to this offering have been filed with the SEC. Electronic
copies of the preliminary prospectus supplement and the
accompanying prospectus relating to this offering may be obtained
from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY
10174, at 212-895-3745. Electronic copies of the preliminary
prospectus supplement and accompanying prospectus are also
available on the website of the SEC at www.sec.gov.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such
state or jurisdiction.
About Milestone Scientific
Inc.
Milestone Scientific Inc. (MLSS) is a medical
device company that patents, designs, develops and commercializes
innovative diagnostic and therapeutic injection technologies and
instruments for medical, dental, cosmetic and veterinary
applications. Milestone's computer-controlled systems are designed
to make injections precise, efficient, and virtually painless.
Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is
our technology platform that advances the development of
next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions
for local anesthesia for subcutaneous drug delivery, with specific
applications for cosmetic botulinum toxin injections, epidural
space identification in regional anesthesia procedures and
intra-articular joint injections. For more information please visit
our website: www.milestonescientific.com.
Safe Harbor StatementThis press
release contains forward-looking statements regarding the timing
and financial impact of Milestone's ability to implement its
business plan, expected revenues, timing of regulatory approvals
and future success. These statements involve a number of risks and
uncertainties and are based on assumptions involving judgments with
respect to future economic, competitive and market conditions,
future business decisions and regulatory developments, all of which
are difficult or impossible to predict accurately and many of which
are beyond Milestone's control. Some of the important factors that
could cause actual results to differ materially from those
indicated by the forward-looking statements are general economic
conditions, failure to achieve expected revenue growth, changes in
our operating expenses, adverse patent rulings, FDA or legal
developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time
to time in Milestone's periodic filings with the Securities and
Exchange Commission, including without limitation, Milestone's
Annual Report for the year ended December 31, 2017. The forward
looking statements in this press release are based upon
management's reasonable belief as of the date hereof. Milestone
undertakes no obligation to revise or update publicly any
forward-looking statements for any reason.
Contact:David Waldman or
Natalya RudmanCrescendo Communications, LLCEmail:
mlss@crescendo-ir.comTel: 212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Sep 2023 to Sep 2024